Sumanpreet KAUR, Veenu GUPTA, Deepinder Kaur CHHİNA, Akashdeep SİNGH, Daaman SHARMA

Mycological and Serological Study of Invasive Aspergillosis in A Tertiary Care Hospital

Objectives: Invasive aspergillosis (IA) has emerged as a major life threatening infection in high risk patients. Recent advances have led to early diagnosis of IA by detecting Aspergillus antigens in serum particularly Galactomannan (GM). Objective of the study was to correlate fungal smear, culture and Galactomannan assay in patients with suspected IA and to categorize them into “proven,” “probable,” and “possible,” cases as per European Organization for Research and Treatment of Cancer and Mycoses study group case definitions (EORTC/MSG) criteria. Methods: The prospective study was conducted over a period of one year in the department of Microbiology, Dayanand Medical College and Hospital, Ludhiana. A total of 319 patients with suspicion of IA were included in the study. GM antigen detection test was done from serum samples. KOH mount was done and samples were inoculated on Sabouraud’s dextrose agar (SDA). Growth obtained was analyzed as per standard protocol. Results: GM assay positivity among suspected patients of IA was 47%. The mean age group affected was 51.8 years (51.8±15.2) and majority was males (78.1%). The patients were categorized as Proven IA (0%), Probable IA (52.7%), Possible IA (41.4%) and No IA (5.9%). Aspergillus flavus was the most common isolate (77.4%) Conclusion: The study demonstrated that serological tests have an edge over routine smear and culture for the diagnosis of invasive aspergillosis. Thus, Galactomannan assay is a useful diagnostic for early detection of IA in high risk patients. J Microbiol Infect Dis 2018; 8(1):8-12

Keywords:

Galactomannan assay, Invasive aspergillosis, Fungal culture, Fungal smear,

PDF

___

REFERENCES 1. George R, Thompson III, Thomas F. Patterson. Pulmonary Aspergillosis. Semin Respir Crit Care Med. 2008; 29:103-110. 2. Shah A, Panjabi C. Allergic aspergillosis of the respiratory tract. Eur Respir Rev 2014; 23(131):8-29. 3. Baddley JW. Clinical risk factors for invasive aspergillosis. Med Mycol 2011; 49:S7-S12. 4. Anaissie EJ, Stratton SL, Dignani MC, et al. Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study. Clin Infect Dis 2002;b34:780-789. 5. Khanna S, Oberoi JK, Datta S, Aggarwal S, Wattal C. Variables affecting the performance of Galactomannan assay in high-risk patients at a Tertiary Care Centre in India. Indian J Med Microbiol 2013; 31(1):34-9. 6. Ruhnke M, Böhme A, Buchheidt D, et al. Diagnosis of invasive fungal infections in hematology and oncology-guidelines of the infectious diseases working party (AGIHO) of the German society of Hematology and Oncology (DGHO). Ann Oncol 2012; 23:823-833. 7. Barton RC. Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome. Scientifica 2013:1-29. 8. Franquet T, Müller NL, Giménez A, Guembe P, de La Torre J, Bagué S. Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings. Radiographics. 2001; 21:825-837. 9. Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev 2011; 20:156-174. 10. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347(6):408-415. 11. Khorvash F, Meidani M, Babaei L, Abbasi S, Ataei B, Yaran M. Galactomannan antigen assay from bronchoalveolar lavage fluid in diagnosis of invasive pulmonary aspergillosis in intensive care units patients. Adv Biomed Res 2014; 3:68-70. 12. Cordonnier C, Botterel F, Ben Amor R, Pautas C, Maury S, Kuentz M. Correlation between Galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis. Clin Microbiol Infect 2009; 15:81-86. 13. Maertens J, Eldere JV, Verhaegen J, Verbeken E, Verschakelen J, Boogaerts M. Use of circulating Galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients. J Infect Dis 2002; 186:1297-1306. 14. Xess I, Mohanty S, Jain N, Banerjee U. Prevalence of Aspergillus species in clinical samples isolated in an Indian tertiary care hospital. Indian J Med Sci 2004; 58(12):513-519. 15. Subirà M, Martino R, Rovira M, Vazquez L, Serrano D, De La Cámara R. Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Ann Hematol 2003; 82:80-82. 16. Tutar N, Metan G, Koc AN, et al. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Multidiscip Respir Med 2013; 8(1):59.

Journal of Microbiology and Infectious Diseases-Cover

ISSN: 2146-3158
Başlangıç: 2011
Yayıncı: Sağlık Araştırmaları Derneği

Arşiv